TXMD

TherapeuticsMD (TXMD)

TherapeuticsMD Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TXMD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	05:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TXMD	TherapeuticsMD Inc
2024/05/11	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2024/05/11	05:05	Business Wire	TherapeuticsMD Announces First Quarter 2024 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2024/03/30	05:00	Business Wire	TherapeuticsMD Announces Full Year 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/12/08	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/12/07	01:36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/17	23:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/17	23:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/11/15	06:05	Business Wire	TherapeuticsMD Announces Third Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/22	05:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/22	05:20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/19	06:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/08/14	19:50	Business Wire	TherapeuticsMD Announces Second Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/20	06:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/11	06:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/07/07	05:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	21:29	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/30	06:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXMD	TherapeuticsMD Inc
2023/06/28	20:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/18	06:05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/18	06:02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05:38	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/16	05:05	Business Wire	TherapeuticsMD Announces First Quarter 2023 Financial Results	NASDAQ:TXMD	TherapeuticsMD Inc
2023/05/06	06:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TXMD	TherapeuticsMD Inc